This review will discuss the various therapeutic techniques being developed from each level of the central dogma with examples including: CRISPR activation (CRISPRa) and gene replacement at the DNA level, antisense oligonucleotides (ASOs) at the mRNA level, and small-molecule drugs at the protein level, followed by a review of current delivery methods for these therapeutics
Institutional protocols discard vials at 28 days regardless of remaining volume, prioritizing data integrity over cost savings
Insulin and glucagon are both anti-ketogenic b
NHS eligibility criteria under NICE TA875 are more restrictive than the MHRA licence, with specific BMI thresholds and service requirements
It means the responsible way to consider it is with a physician who'll tell you what we know, what we don't, and whether it makes sense for your specific situation
T0901317 is a potent PXR ligand: implications for the biology ascribed to LXR